These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1374178)

  • 1. Volume of normal prostate, of prostate cancer, and of benign prostatic hyperplasia: are correlations with prostate specific antigen clinically useful?
    Clements R; Penney MD; Etherington RJ; Griffiths GJ; Hughes H; Peeling WB
    Prostate Suppl; 1992; 4():51-7. PubMed ID: 1374178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between prostate-specific antigen and prostate volume, evaluated by transrectal ultrasonography: usefulness in diagnosis of prostate cancer.
    Veneziano S; Pavlica P; Querzé R; Nanni G; Lalanne MG; Vecchi F
    Eur Urol; 1990; 18(2):112-6. PubMed ID: 1699766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of studies of prostate-specific antigen and prostate-specific antigen density in patients with prostatic hypertrophy and prostatic cancer].
    Romics I; Bodrogi I; Frang D
    Orv Hetil; 1995 Jul; 136(30):1599-602. PubMed ID: 7543669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of prostate-specific antigen and prostate volume in patients with biopsy proven benign prostatic hyperplasia.
    Hochberg DA; Armenakas NA; Fracchia JA
    Prostate; 2000 Dec; 45(4):315-9. PubMed ID: 11102956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-relation between measurement of serum prostatic specific antigen and transrectal ultrasound in the diagnosis of benign prostatic hyperplasia and prostatic cancer.
    Clements R; Etherington RJ; Griffiths GJ; Peeling WB; Hughes H; Penney MD
    Br J Urol; 1992 Aug; 70(2):183-7. PubMed ID: 1382795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of specific prostatic antigen to prostatic volume ratio in the selection of patients for ultrasonography-guided biopsy of the prostate].
    Veneziano S; Pavlica P; Querzè R; Viglietta G; Trenta A
    Radiol Med; 1991 Jun; 81(6):857-60. PubMed ID: 1713333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
    Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
    J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicted prostate specific antigen results using transrectal ultrasound gland volume. Differentiation of benign prostatic hyperplasia and prostate cancer.
    Lee F; Littrup PJ; Loft-Christensen L; Kelly BS; McHugh TA; Siders DB; Mitchell AE; Newby JE
    Cancer; 1992 Jul; 70(1 Suppl):211-20. PubMed ID: 1376190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review.
    Al-Khalil S; Boothe D; Durdin T; Sunkara S; Watkins P; Yang S; Haynes A; de Riese W
    Int Urol Nephrol; 2016 Jan; 48(1):91-7. PubMed ID: 26590832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ability of systematic transrectal ultrasound guided biopsy to detect prostate cancer in men with the clinical diagnosis of benign prostatic hyperplasia.
    Coplen DE; Andriole GL; Yuan JJ; Catalona WJ
    J Urol; 1991 Jul; 146(1):75-7. PubMed ID: 1711588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anatomoclinical and biologic correlations in prostatic pathology. Apropos of 150 case reports].
    Amiel J; Chevallier D; Peyrottes A; Benoliel J; Toubol J
    Ann Urol (Paris); 1989; 23(6):528-30. PubMed ID: 2482700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of prostatic cancer metastatic disease using prostate-specific antigen.
    Vesey SG; Goble M; Ferro MA; Stower MJ; Hammonds JC; Smith PJ
    Urology; 1990 Jun; 35(6):483-6. PubMed ID: 1693796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in serum prostate-specific antigen following prostatectomy in patients with benign prostate hyperplasia.
    Furuya Y; Akakura K; Tobe T; Ichikawa T; Igarashi T; Ito H
    Int J Urol; 2000 Dec; 7(12):447-51. PubMed ID: 11168683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen and prostate gland volume: correlation and clinical application.
    Babaian RJ; Fritsche HA; Evans RB
    J Clin Lab Anal; 1990; 4(2):135-7. PubMed ID: 1690280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathologic and biological correlations (PSA-PAP) in pathology of the prostate. Apropos of 150 cases].
    Amiel J; Chevallier D; Peyrottes A; Benoliel J; Toubol J
    J Urol (Paris); 1990; 96(4):199-201. PubMed ID: 1698882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease.
    Carter HB; Morrell CH; Pearson JD; Brant LJ; Plato CC; Metter EJ; Chan DW; Fozard JL; Walsh PC
    Cancer Res; 1992 Jun; 52(12):3323-8. PubMed ID: 1375867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD44 molecules in serum of patients with prostate cancer and benign prostatic hyperplasia.
    Jung K; Lein M; Weiss S; Schnorr D; Henke W; Loening S
    Eur J Cancer; 1996 Apr; 32A(4):627-30. PubMed ID: 8695265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The incidence of lesions associated with prostatic biopsy and its effect on the serum concentration of the prostate-specific antigen].
    Morote Robles J; López López M; Encabo Duro G; de Torres Ramírez I
    Actas Urol Esp; 1999 May; 23(5):400-5. PubMed ID: 10427813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease.
    Carter HB; Pearson JD; Metter EJ; Brant LJ; Chan DW; Andres R; Fozard JL; Walsh PC
    JAMA; 1992 Apr 22-29; 267(16):2215-20. PubMed ID: 1372942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.